Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.marketwatch.com/story/study-finds-pfizers-antiviral-has-little-or-zero-benefit-for-younger-adults-and-who-says-ba-5-omicron-subvariant-accounted-for-74-of-cases-in-latest-week-11661438030
0
0
Study finds Pfizer's antiviral has little or even zero benefit for younger adults, and WHO says BA.5 omicron subvariant accounted for 74% of cases in latest week - MarketWatch
8/25/22 at 7:33am
Organization
MarketWatch
Author
Ciara Linnane
Details
41 words
Summarize
Infectious Diseases
Health
Pfizer
74%
omicron subvariant
omicron subvariant
Omicron
Omicron now accounts for 99% of cases sequenced worldwide, says WHO
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...